Market Cap 28.36M
Revenue (ttm) 0.00
Net Income (ttm) -26.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 358,900
Avg Vol 213,548
Day's Range N/A - N/A
Shares Out 8.70M
Stochastic %K 75%
Beta 1.15
Analysts Strong Buy
Price Target $40.00

Company Profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agree...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 921 1810
Fax: 604 921 1898
Address:
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada
MikeTechnician
MikeTechnician Jul. 7 at 3:02 PM
$BCTX BriaCell is strengthening its commercial strategy by engaging CRA to evaluate market access, pricing, epidemiology and prescriber dynamics for Bria-IMT™, while bringing on Kaleio to lead brand strategy and commercialization planning. Strategic moves like these can help lay the groundwork for long-term value creation as the company advances its oncology platform. https://globenewswire.com/news-release/2026/07/07/3323056/0/en/briacell-engages-consulting-and-branding-firms-to-support-commercial-and-market-access-evaluation-of-bria-imt.html
0 · Reply
SmallCapGrowth
SmallCapGrowth Jul. 7 at 2:35 PM
BB's Stock Haven : $BCTX today announced that it has engage... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177764889 via @Investors_Hub
0 · Reply
Ares77manoe
Ares77manoe Jul. 7 at 2:29 PM
$BCTX f**** hedgies
0 · Reply
JediGreen
JediGreen Jul. 7 at 2:29 PM
0 · Reply
SmallCapGrowth
SmallCapGrowth Jul. 7 at 2:17 PM
$BCTX today announced that it has engaged Charles River Associates (CRA) (Nasdaq: $CRAI) and Kaleio, Inc. to support commercial strategy, market access evaluation and brand planning for Bria-IMT. NEWS: https://bit.ly/3QK1eTD #Biotech #Oncology #HealthcareInvesting
0 · Reply
SmallCapGrowth
SmallCapGrowth Jul. 7 at 1:57 PM
$BCTX BriaCell engages CRA and Kaleio to support commercial strategy and market access evaluation for Bria-IMT™. Big commercial-readiness step. https://www.globenewswire.com/news-release/2026/07/07/3323056/0/en/briacell-engages-consulting-and-branding-firms-to-support-commercial-and-market-access-evaluation-of-bria-imt.html
0 · Reply
CAN29
CAN29 Jul. 7 at 1:40 PM
@BioRich FTI Tuesday, 07/07/2026 9:08:05 AM Another positive milestone for $BCTX as BriaCell expands commercial-readiness efforts for Bria-IMT, its Phase 3 metastatic breast cancer immunotherapy candidate.
0 · Reply
SmallCapGrowth
SmallCapGrowth Jul. 7 at 1:21 PM
Commercial planning underway at $BCTX. CRA will evaluate market access and pricing potential for Bria-IMT, while Kaleio supports brand strategy. NEWS: https://bit.ly/3QK1eTD #Biotech #Oncology #HealthcareInvesting
0 · Reply
SmallCapGrowth
SmallCapGrowth Jul. 7 at 1:15 PM
BB's Stock Haven : Another positive milestone for $BCTX as BriaCell expands commercial-readiness efforts for Bria-IMT... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177764473 via @Investors_Hub
0 · Reply
BHWinehouse
BHWinehouse Jul. 7 at 1:04 PM
$BCTX Watch list continues to grow
0 · Reply
Latest News on BCTX
BriaCell enters MoU with Uneedle for microneedle technology

2026-06-25T11:45:30.000Z - 12 days ago

BriaCell enters MoU with Uneedle for microneedle technology


BriaCell Therapeutics Announces Closing of Offering

Tue, 02 Jun 2026 16:05:00 -0400 - 4 weeks ago

BriaCell Therapeutics Announces Closing of Offering


BriaCell Presents Positive Clinical Data at ASCO 2026

Mon, 01 Jun 2026 07:30:00 -0400 - 5 weeks ago

BriaCell Presents Positive Clinical Data at ASCO 2026


BriaCell Therapeutics Announces Pricing of Offering

Sun, 31 May 2026 19:59:00 -0400 - 5 weeks ago

BriaCell Therapeutics Announces Pricing of Offering


BriaCell announces data from Bria-IMT at ASCO 2026

2026-05-22T11:49:02.000Z - 6 weeks ago

BriaCell announces data from Bria-IMT at ASCO 2026


BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients

Tue, 12 May 2026 07:30:00 -0400 - 2 months ago

BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients


BriaCell receives FDA clearance to initiate Bria-BRES+ trial

2026-05-07T04:03:56.000Z - 2 months ago

BriaCell receives FDA clearance to initiate Bria-BRES+ trial


BriaCell Announces Six Clinical Data Presentations at ASCO 2026

Mon, 27 Apr 2026 07:30:00 -0400 - 2 months ago

BriaCell Announces Six Clinical Data Presentations at ASCO 2026


BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting

2026-04-21T13:28:43.000Z - 2 months ago

BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting


BriaCell presents anti-cancer activity of Bria-OTS

2026-04-21T11:54:23.000Z - 2 months ago

BriaCell presents anti-cancer activity of Bria-OTS


BriaCell to present four posters at the 2026 AACR

2026-03-18T11:42:55.000Z - 3 months ago

BriaCell to present four posters at the 2026 AACR


BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

Thu, 05 Mar 2026 16:04:00 -0500 - 4 months ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting


BriaCell (BCTX) Reports Promising Phase 2 Survival Data

2026-01-27T13:32:37.000Z - 5 months ago

BriaCell (BCTX) Reports Promising Phase 2 Survival Data


Is the Market Bullish or Bearish on BriaCell Therapeutics Corp?

2026-01-19T16:00:45.000Z - 6 months ago

Is the Market Bullish or Bearish on BriaCell Therapeutics Corp?


BriaCell Therapeutics trading resumes

2026-01-13T14:41:11.000Z - 6 months ago

BriaCell Therapeutics trading resumes


BriaCell Therapeutics trading halted, volatility trading pause

2026-01-13T14:35:29.000Z - 6 months ago

BriaCell Therapeutics trading halted, volatility trading pause


BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

Oct 20, 2025, 7:30 AM EDT - 9 months ago

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025


BriaCell Announces Proposed Effective Date of Share Consolidation

Aug 21, 2025, 12:00 PM EDT - 11 months ago

BriaCell Announces Proposed Effective Date of Share Consolidation


MikeTechnician
MikeTechnician Jul. 7 at 3:02 PM
$BCTX BriaCell is strengthening its commercial strategy by engaging CRA to evaluate market access, pricing, epidemiology and prescriber dynamics for Bria-IMT™, while bringing on Kaleio to lead brand strategy and commercialization planning. Strategic moves like these can help lay the groundwork for long-term value creation as the company advances its oncology platform. https://globenewswire.com/news-release/2026/07/07/3323056/0/en/briacell-engages-consulting-and-branding-firms-to-support-commercial-and-market-access-evaluation-of-bria-imt.html
0 · Reply
SmallCapGrowth
SmallCapGrowth Jul. 7 at 2:35 PM
BB's Stock Haven : $BCTX today announced that it has engage... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177764889 via @Investors_Hub
0 · Reply
Ares77manoe
Ares77manoe Jul. 7 at 2:29 PM
$BCTX f**** hedgies
0 · Reply
JediGreen
JediGreen Jul. 7 at 2:29 PM
0 · Reply
SmallCapGrowth
SmallCapGrowth Jul. 7 at 2:17 PM
$BCTX today announced that it has engaged Charles River Associates (CRA) (Nasdaq: $CRAI) and Kaleio, Inc. to support commercial strategy, market access evaluation and brand planning for Bria-IMT. NEWS: https://bit.ly/3QK1eTD #Biotech #Oncology #HealthcareInvesting
0 · Reply
SmallCapGrowth
SmallCapGrowth Jul. 7 at 1:57 PM
$BCTX BriaCell engages CRA and Kaleio to support commercial strategy and market access evaluation for Bria-IMT™. Big commercial-readiness step. https://www.globenewswire.com/news-release/2026/07/07/3323056/0/en/briacell-engages-consulting-and-branding-firms-to-support-commercial-and-market-access-evaluation-of-bria-imt.html
0 · Reply
CAN29
CAN29 Jul. 7 at 1:40 PM
@BioRich FTI Tuesday, 07/07/2026 9:08:05 AM Another positive milestone for $BCTX as BriaCell expands commercial-readiness efforts for Bria-IMT, its Phase 3 metastatic breast cancer immunotherapy candidate.
0 · Reply
SmallCapGrowth
SmallCapGrowth Jul. 7 at 1:21 PM
Commercial planning underway at $BCTX. CRA will evaluate market access and pricing potential for Bria-IMT, while Kaleio supports brand strategy. NEWS: https://bit.ly/3QK1eTD #Biotech #Oncology #HealthcareInvesting
0 · Reply
SmallCapGrowth
SmallCapGrowth Jul. 7 at 1:15 PM
BB's Stock Haven : Another positive milestone for $BCTX as BriaCell expands commercial-readiness efforts for Bria-IMT... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177764473 via @Investors_Hub
0 · Reply
BHWinehouse
BHWinehouse Jul. 7 at 1:04 PM
$BCTX Watch list continues to grow
0 · Reply
Biohero
Biohero Jul. 7 at 1:02 PM
$BCTX the stock is absolutely ridiculously cheap, i keep on adding shares. Pipeline for free at 30m$ marketcap. Never seen such an undervalued p3-biotech-stock. Event 144 incoming!
1 · Reply
SmallCapGrowth
SmallCapGrowth Jul. 7 at 1:02 PM
Commercial planning underway at $BCTX . CRA will evaluate market access and pricing potential for Bria-IMT, while Kaleio supports brand strategy. NEWS: https://bit.ly/3QK1eTD #Biotech #Oncology #HealthcareInvesting
0 · Reply
SmallCapGrowth
SmallCapGrowth Jul. 7 at 12:58 PM
BriaCell Therapeutics Corp ( $BCTX ): $BCTX News! BriaCell Engages Consulting... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177764366 via @Investors_Hub
0 · Reply
SmallCapGrowth
SmallCapGrowth Jul. 7 at 12:52 PM
$BCTX IS building the foundation for potential commercialization of Bria-IMT with new partnerships focused on market access and branding strategy. NEWS: https://bit.ly/3QK1eTD #BiotechStocks #CancerResearch #SmallCapStocks
0 · Reply
I_H8_SHORTS
I_H8_SHORTS Jul. 7 at 12:45 PM
$BCTX How is this trading at only a 30 million $ market cap (= to cash on hand) while pure garbage trades at 50x the MC?
0 · Reply
rp6577
rp6577 Jul. 7 at 12:21 PM
$BCTX they at expecting full approval of the back of the phase 3 results. Market cap should be way higher than it is now
0 · Reply
Ares77manoe
Ares77manoe Jul. 7 at 12:14 PM
$BCTX today news and +2% pre market...Please...please where is the f**** SEC...This a s**** showtime. Meanwhile stocks like WTO are trading with crooks. Everything is perfect.
0 · Reply
I_H8_SHORTS
I_H8_SHORTS Jul. 7 at 11:44 AM
$BCTX If Big Pharma wants to buy out BCTX, better open their wallets soon as buyers are probably lining up. Where does the bidding Start? Any guesses.. for a multi BILLION dollar pipeline...
0 · Reply
I_H8_SHORTS
I_H8_SHORTS Jul. 7 at 11:38 AM
$BCTX Looks like they are planning on FDA approval. Nice
0 · Reply
SmallCapVoice
SmallCapVoice Jul. 7 at 11:32 AM
BriaCell is strengthening its commercial strategy by engaging CRA to evaluate market access, pricing, epidemiology and prescriber dynamics for Bria-IMT™, while bringing on Kaleio to lead brand strategy and commercialization planning. Strategic moves like these can help lay the groundwork for long-term value creation as the company advances its oncology platform. $BCTX https://www.globenewswire.com/news-release/2026/07/07/3323056/0/en/briacell-engages-consulting-and-branding-firms-to-support-commercial-and-market-access-evaluation-of-bria-imt.html
0 · Reply
data_dave
data_dave Jul. 7 at 9:57 AM
$GILT $BCTX $OSPN $IP.MI — my "misread re-rating" watchlist, shared with honest pros & cons. I hold all four. $GILT: Comtech deal builds a defense/aviation sat-comms story with a Re-Rating Case maybe , but 44% of revenue sits with 2 customers (With Comtech US Army License in House). My model recently downgraded it from Buy to REJECT — integration unproven. Still long $OSPN: net cash, auth/cyber pivot. But market reads hardware, reality is SaaS. Model say "Watch" now. $IP.MI: global leader in high-pressure pumps, ~22% margin of safety, but 2 years of flat/declining revenue — also REJECT in my model now. $BCTX: Phase-3 oncology, positive DSMB, but a pure research position for me — no systematic buy signal, high dilution risk. Not bullish calls — I hold these with full respect for the risks. Not financial advice. No solicitation or offer. I am long the names above (conflict of interest). Do your own research; positions may change without notice. You bear all risk of loss.
1 · Reply
Silo46
Silo46 Jul. 6 at 10:10 PM
$BCTX I held Bctx . It later changed to Bria pro, or something maybe. But as of now fidelity shows all blanks for this position. advisor says he can’t find it and says maybe it’s delisted. Can someone tell me what’s going on with this? How do I sell it to claim Loss?
3 · Reply